MUC2 and neoplasm: Dexamethasone also significantly reduced mucinous tumor mass in a PMP xenograft model, decreasing not only MUC2 content but also the number of tumor cells, suggesting that this drug in PMP might exert a dual role as inhibitor of mucin production and cell proliferation [87].